Australia markets open in 6 hours 44 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
28.41-0.55 (-1.92%)
As of 11:15AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Research development
246,788
161,855
103,303
50,294
Selling general and administrative
78,303
58,243
45,813
33,169
Total operating expenses
325,091
220,098
149,116
83,463
Operating income or loss
-325,091
-220,098
-149,116
-83,463
Total other income/expenses net
3,546
-5,393
-3,274
-46,433
Income before tax
-317,758
-225,334
-152,166
-128,344
Income tax expense
0
0
-24
45
Income from continuing operations
-317,758
-225,334
-152,142
-128,389
Net income
-317,758
-225,334
-152,142
-128,389
Net income available to common shareholders
-317,758
-225,334
-152,142
-128,389
Basic EPS
-
-1.65
-2.01
-1.01
Diluted EPS
-
-1.65
-2.01
-1.01
Basic average shares
-
136,577
73,643
127,124
Diluted average shares
-
136,577
73,643
127,124
EBITDA
-
-217,367
-148,719
-83,286